Find out how much you know with these random facts and trivia questions on movies, music, history, science, geography and so ...
After Johnson & Johnson last year changed its mind on its 2017 purchase of aprocitentan, the medicine's original maker has ushered the drug across the FDA finish line. The once-daily drug, branded as ...
Idorsia’s plans to sell its hypertension drug Tryvio have faced a speed bump, even as the biotech plows ahead with around 250 layoffs. Last month, the company said it had secured a $35 million ...
With the latest hopes of licensing its hypertension drug Tryvio falling through, Idorsia has moved to claw back $100 million in upcoming development costs from a separate deal with Viatris. Idorsia ...
(RTTNews) - Idorsia Ltd (IDRSF. OB) announced that the US Food & Drug Administration, after having released TRYVIO from its Risk Evaluation and Mitigation Strategy or REMS requirement, has now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results